TABLE 2. 1H NMR Spectra of the Synthesized Compounds
Com-
pound
Chemical shifts, δ, ppm (J, Hz)
0.95 (3Н, t, J = 6.8, СН3); 1.21-3.21 (23H, m, 11СН2, 8'-CH); 8.15 (1Н, s, NH)
0.93 (3Н, t, J = 6.8, СН3); 1.05-3.23 (25H, m, 12CН2, 8'-CH); 8.14 (1Н, s, NH)
0.91 (9Н, s, 3СН3); 1.05-3.22 (21H, m, 10СН2, 8'-CH); 8.15 (1Н, s, NH)
1.05-3.65 (23H, m, 11СН2, 8'-CH); 7.33-7.51 (5Н, m, H Ph); 8.15 (1Н, s, NH)
1.00-3.25 (25Н, m, 12CН2, 8'-CH); 7.11-7.46 (5Н, m, H Ph); 8.15 (1Н, s, NH)
1.00-3.25 (22Н, m, 10CН2, 2CH); 7.52-7.83 (10Н, m, H Ph); 8.13 (1Н, s, NH)
1.00-3.51 (25Н, m, 12CН2, 8'-CH); 8.15 (1Н, s, NH)
2b
2c
2d
2e
2f
2g
2h
2i
0.94 (3Н, t, J = 7.0, CH2СН3); 1.22-3.25 (23H, m, 11СН2, 8'-CH);
4.23 (2Н, q, J = 7.0, СН2СН3); 8.15 (1Н, s, NH)
1.20-3.18 (32Н, m, 15CН2, 2CH); 8.15 (1Н, s, NH)
2j
0.95-3.21 (58Н, m, CH3, 27CН2, 8'-CH); 8.14 (1Н, s, NH)
1.10-3.25 (25H, m, 12СН2, 8'-CH); 4.72 (1Н, s, ОН); 8.15 (1Н, s, NH)
1.07-3.15 (27H, m, 13СН2, 8'-CH); 4.81 (1Н, s, ОН); 8.15 (1Н, s, NH)
2k
2l
2m
2n
1.10-3.19 (27H, m, 13СН2, 8'-CH); 3.73 (2Н, m, OCHСН2);
4.03 (1Н, t, J = 7.1, OCHCH2); 8.15 (1Н, s, NH)
1.10-3.19 (23H, m, 11СН2, 8'-CH); 6.06 (1Н, d, J = 6.7, H-3''); 6.25 (1Н, t, J = 7.0, H-4'');
7.32 (1Н, d, J = 7.1, H-5''); 8.14 (1Н, s, NH)
2o
2p
1.10-3.24 (25H, m, 12СН2, 8'-CH); 3.73 (6Н, s, 2ОСН3); 6.52-6.61 (3Н, m, H Ar);
8.15 (1Н, s, NH)
4а*
4b*
4c*
4d*
6а
1.50-2.60 (11Н, m, 5CН2, 5-CH); 2.27 (3Н, s, СН3); 7.85 (2Н, s, NH2)
0.95 (3Н, s, СН3); 1.21-2.58 (15Н, m, 7CН2, 5-CH); 7.85 (2Н, s, NH2)
1.50-2.60 (13Н, m, 6CН2, 5-CH); 7.21-7.63 (5Н, m, H Ph); 7.85 (2Н, s, NH2)
1.20-2.74 (22Н, m, 10CН2, 2CH); 7.85 (2Н, s, NH2)
0.95-2.60 (19Н, m, 9СН2, 8-CH); 2.27 (6Н, s, 2СН3); 6.70 (1Н, s, NH); 7.73 (1Н, s, NH)
1.00 (6Н, s, 2СН3); 1.22-2.65 (23Н, m, 11СН2, 8-CH); 6.70 (1Н, s, NH); 7.72 (1Н, s, NH)
6b
1.20-2.65 (23Н, m, 11СН2, 8-CH); 6.71 (1Н, s, NH); 7.06-7.14 (10Н, m, H Ph);
7.73 (1Н, s, NH)
6c
1.00-2.60 (29Н, m, 14СН2, 8-CH); 6.70 (1Н, s, NH); 7.73 (1Н, s, NH)
1.00-2.60 (27Н, m, 13СН2, 8-CH); 6.70 (1Н, s, NH); 7.72 (1Н, s, NH)
6d
6e
6f
1.00-2.48 (25Н, m, 12СН2, 8-CH); 6.70 (1Н, s, NH); 6.54-6.94 (4Н, m, H Ar);
7.73 (1Н, s, NH)
_______
* IR spectra of compounds 4 (, cm-1): a 1703, 1663; b 1705, 1648; c 1710,
1654; d 1710, 1650.
EXPERIMENTAL
IR spectra were recorded on a Bruker ALPHA FT-IR spectrometer in the ATR mode for KBr pellets. 1H
NMR spectra were recorded on a Varian VXR 200 instrument (200 MHz) using DMSO-d6 with TMS as internal
standard. The purity of the prepared compounds was established using TLC on Merck 60 F254 plates in the
system chloroform–ethyl acetate (10:1).
The spiro compound 1 was prepared from cyclohexanone and urea with azeotropic distillation of water
using toluene [10-11]. Compound 2a was prepared in methanol using method [9] in 60% yield, and the
carboxamide 5 was obtained by acid hydrolysis of the spirane 1 [12].
5',6',7',8'-Tetrahydro-4a',8'-(2-ethyl-2-azapropano)-3'H-spiro[cyclohexane-1,2'-quinazolin]-4'-one
(2b). A. Compound 1 (2.200 g, 0.01 mol) and a 36% formalin solution (1.6 ml) were added to a solution of
EtNH2·HCl (0.815 g, 0.01 mol) in MeOH (10 ml) and refluxed on a water bath for 40 min. Solvent was distilled
off under reduced pressure, and the residue was dissolved in water, filtered, and treated with 10% ammonia
solution. The precipitated compound 2b was filtered off, washed with water, and recrystallized from a mixture
of water and methanol. Yield 1.940 g (67%).
928